about
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiaeEpigenetic changes as a common trigger of muscle weakness in congenital myopathies.Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locusMyocyte enhancer factor 2 activates promoter sequences of the human AbetaH-J-J locus, encoding aspartyl-beta-hydroxylase, junctin, and junctateIncrease of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Multiple levels of control of the expression of the human A beta H-J-J locus encoding aspartyl-beta-hydroxylase, junctin, and junctate.A validated cellular biobank for β-thalassemia.Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development.miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Involvement of miRNA in erythroid differentiation.Recent trends for novel options in experimental biological therapy of β-thalassemia.Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functionsPeptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells.Recent trends in the gene therapy of β-thalassemia.Recent patents and technology transfer for molecular diagnosis of β-thalassemia and other hemoglobinopathies.Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line.An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system.miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma.MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells.High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222.Regulation of IL-8 gene expression in gliomas by microRNA miR-93.Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance.Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cellsUptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221.Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses.Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs.Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients.In vitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells.Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function.Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.Isothermal circular-strand-displacement polymerization of DNA and microRNA in digital microfluidic devices.Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis.Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes.An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production.Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells.
P50
Q28551611-42F48BEE-979B-4D30-9DAB-274BCA8E6C1FQ29977760-EFCE878B-E43C-440A-83C9-4ACBA66E4832Q33393444-D9A2ACA3-ADB5-4685-BD92-7CF1D73CEC67Q33724398-C0C02440-C1F0-48C5-A705-3CC3B11F6E70Q35301892-72E29329-2866-4C93-BC0A-36E31863DE3BQ36611332-F7359568-40A1-4CCA-A908-8E578E6B5B27Q36753116-AEB60966-E3A5-4FBC-8CA9-5788351B617FQ37230919-B701AE14-1176-4ADA-863F-13476DF63C0EQ37921863-6E367DF6-030F-492A-BD71-79097A703C8BQ37962609-7A757D71-9B30-49C1-A803-1989754C5D27Q37983889-001982F8-D316-4E9F-A915-767FB1E025E3Q38220695-CAA2D881-D2E6-4F94-871C-911BED4300CFQ38299426-62AA2E0B-D6EF-4EB2-958A-62AF2DF2C1D6Q38302444-E1C665B5-D321-48B9-BA7B-3C4DD55A94F8Q38321556-48C075C1-1EF8-49FA-95F8-05C80F249A09Q38367473-027E1F8B-7BD5-46DC-8748-DD2C1FB42AFCQ38594354-D1E16635-4E33-41FE-94C5-7F5FEBA703FAQ38704768-6674C3A9-35DC-498B-B827-937DAB091989Q38717666-417B8EFC-2385-4086-B097-7AE9EF243F48Q38779883-511DA610-E897-4CD4-9E6D-5DBBA3255439Q38785524-C0073EA8-78C4-447A-B2D0-823C26A8F8C6Q38808735-BDEF9BAA-2410-43DC-BFCA-9F55787AE845Q38829417-75F83043-B80D-4116-A757-C7801A205A49Q38911516-75CFB858-56F0-44F1-B040-96C6FF1EAAAAQ38939602-A5E35F81-A07F-42CD-BDF0-27545C068B20Q39018554-CF1EE9BB-A40A-4D4A-8764-E79E39CF67CFQ39033925-FC9F2006-F937-4394-8A9B-6000B7ABF15AQ39069391-491200C6-84B3-434C-862A-F40744645A38Q39318131-F082725D-8D4C-4F3C-8990-E42F9CE333A0Q39388051-CD99D77E-3F72-4E77-8959-67456F4EC063Q39428800-E3AEEDBA-09DF-4F8F-BB91-42666471A1E8Q39455677-8323AD41-EC60-4782-9ACE-728B821A30FDQ39621248-B513A0F7-1D69-40E3-A6EA-07EA1AB48F3AQ39795854-EF149D7E-4423-4DA5-94AF-E6BD6DD110C6Q40248933-E218904D-BDF0-4EDB-85EC-1F984C13373AQ40476858-1397E7BD-B965-4E48-93D4-9CE0B73ACE41Q40746113-52982821-A9DF-48DD-A923-68EE8B5E7182Q41163641-0F44701B-75D3-41F5-ACB9-9F5E28D8DA6AQ41554655-071C796B-E34A-4E8B-ACFA-DD6EB664BAFBQ42496609-DC6FF22D-D74C-497C-9AD9-33565D584F88
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessia Finotti
@ast
Alessia Finotti
@en
Alessia Finotti
@es
Alessia Finotti
@nl
Alessia Finotti
@sl
type
label
Alessia Finotti
@ast
Alessia Finotti
@en
Alessia Finotti
@es
Alessia Finotti
@nl
Alessia Finotti
@sl
prefLabel
Alessia Finotti
@ast
Alessia Finotti
@en
Alessia Finotti
@es
Alessia Finotti
@nl
Alessia Finotti
@sl
P1053
C-6268-2012
P106
P1153
6506289571
P21
P31
P3829
P496
0000-0002-7638-515X